← Leaderboards
Michael Roberts
University Of South Australia
$3,136,991
Attributed
$4,174,478
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $750K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$4,174,478 · 5
By mechanism
U01$4,174,478 · 5
Top collaborators
- Yousuf Hussain Mohammed7 shared
- Sarika Namjoshi2 shared
Grant awards (17)
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$75,000
U01 · FY2022 · FD · contact PI
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$250,000
U01 · FY2021 · FD · contact PI
Elucidating Sensorial and Functional Characteristics of Topical Formulations$499,990
U01 · FY2020 · FD
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$249,994
U01 · FY2020 · FD · contact PI
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems$250,000
U01 · FY2019 · FD · contact PI
Elucidating Sensorial and Functional Characteristics of Topical Formulations$250,000
U01 · FY2019 · FD
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$249,994
U01 · FY2019 · FD · contact PI
Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations$250,000
U01 · FY2018 · FD · contact PI
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2018 · FD · contact PI
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems$250,000
U01 · FY2018 · FD · contact PI
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2017 · FD · contact PI
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$250,000
U01 · FY2016 · FD · contact PI
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2016 · FD · contact PI
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$249,750
U01 · FY2015 · FD · contact PI
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2015 · FD · contact PI
Characterization of Critical Quality Attributes for Semisolid Topical Drug Products$249,750
U01 · FY2014 · FD · contact PI
Physiologically Based Biopharmaceutics and Pharmacokinetics of Drug Products for Dermal Absorption in Humans$200,000
U01 · FY2014 · FD · contact PI